Actively Recruiting
Intensive Prevention Program After Decompensated Heart Failure
Led by Herzzentrum Bremen · Updated on 2026-03-16
200
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
Sponsors
H
Herzzentrum Bremen
Lead Sponsor
N
Nationale Herzallianz (NHA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Introduction: Care for patients with heart failure (HF) often remains inadequate, even though a variety of treatment options exist. Guideline-based, multimodal therapy is rarely fully established, partly due to insufficient intersectoral cooperation and insufficient patient training. Heart failure nurses (HFN) as specialized non-medical personnel are intended to contribute to better patient care. E-learning and the use of mobile devices are modern options for training patients. However, previous studies in this regard only examined a few aspects of therapy and came to different results. The Intensive Prevention Program after decompensated Heart Failure (IPP-HF) will investigate if a one-year web-based and HFN-guided program for patients hospitalized due to congestive heart failure leads to a lower rate of re-hospitalization and an improvement in quality of life (QoL). Study design: Patients hospitalized for decompensated HF will be prospectively enrolled and assigned to either a 12 months HFN-guided intensive prevention program or standard care. The prevention program will include patient training per e-learning, use of an app for HF, linking the patient to an interdisciplinary heart failure network and referral to heart sports groups or other specialists and will include regular monitoring for signs of (threatening) decompensation, medication, fitness and QoL. The combined primary study endpoint will comprise rehospitalization for decompensated HF and QoL after 1 year. Secondary endpoints will include mortality, completeness of anticongestive medication, changes in ejection fraction, NTproBNP, ferritin, transferrin, 6-minute walking distance, relative maximum oxygen-consumption (peak VO2), NYHA-class, depression status (PHQ-9) and knowledge about HF (AHFKT). Conclusions :The randomized IPP-HF study will evaluate the effect of an web-based and HFN-guided prevention program on rehospitalization and QoL for patients hospitalized for decompensated heart failure.
CONDITIONS
Official Title
Intensive Prevention Program After Decompensated Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalization due to symptomatic heart failure (NYHA II-IV) with signs of congestion, ejection fraction 60;40%, and elevated NTproBNP
- Age between 18 and 80 years
- Life expectancy greater than 2 years
- Access to internet, physical and mental ability, and consent to participate in a web-based prevention program guided by heart failure nurses
You will not qualify if you...
- Persistent NYHA IV at discharge
- Reversible cause of heart failure (e.g., tachycardiomyopathy, acute myocarditis, pacemaker-induced heart failure)
- Ejection fraction greater than 40% (HFmrEF, HFpEF)
- Refusal or inability to give informed consent
- Participation in another clinical trial
- Exercise limitations due to non-heart failure conditions (e.g., disabling orthopedic, rheumatological, hematooncological, neurological diseases, severe lung diseases)
- Major non-cardiac conditions adversely affecting survival (e.g., malignant comorbidities or end-stage liver cirrhosis with prognosis less than 2 years)
- Inability to cooperate with the study protocol (e.g., chronic active drug/alcohol abuse, severe mental disorders, deafness or severe language barrier without translation, inability to attend study visits)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bremen Institute for Heart- and Circulation Research
Bremen, Germany, 28277
Actively Recruiting
Research Team
S
Stephan Ruehle
CONTACT
H
Harm Wienbergen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here